- Report
- March 2024
- 189 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- November 2023
- 175 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- May 2023
- 111 Pages
Global
From €4347EUR$4,500USD£3,717GBP
- Report
- February 2024
- 109 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- January 2024
- 165 Pages
Global
From €4782EUR$4,950USD£4,089GBP
- Report
- November 2023
- 303 Pages
Global
From €5313EUR$5,500USD£4,543GBP
- Report
- March 2024
- 182 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- March 2024
- 181 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- February 2024
- 175 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- February 2024
- 175 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- October 2023
- 139 Pages
Global
From €2414EUR$2,499USD£2,064GBP
- Report
- May 2024
- 263 Pages
Global
From €5409EUR$5,600USD£4,626GBP
- Report
- February 2024
- 120 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 114 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- April 2024
- 180 Pages
Global
From €4733EUR$4,900USD£4,047GBP
- Report
- November 2023
- 172 Pages
Global
From €4733EUR$4,900USD£4,047GBP
- Report
- October 2023
- 178 Pages
Global
From €4733EUR$4,900USD£4,047GBP
- Report
- February 2024
- 114 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- May 2023
- 292 Pages
Global
From €3477EUR$3,600USD£2,974GBP
- Report
- May 2023
- 115 Pages
Middle East, Africa
From €1449EUR$1,500USD£1,239GBP
Within the realm of animal healthcare and veterinary medicine, the Companion Animal Vaccine market is an essential segment focused on the immunization of pets, such as dogs, cats, and horses, against various infectious diseases. This sector addresses the preventative healthcare needs of companion animals by providing a variety of vaccines that target illnesses such as rabies, distemper, parvovirus, and feline leukemia, among others. The availability and development of these vaccines are driven by continuous scientific research, technological advancements, and an increasing awareness among pet owners about the importance of preventative care. Moreover, this market is influenced by regulatory frameworks and animal welfare organizations advocating for the health and safety of companion animals. The administration of vaccines is a critical component of routine veterinary care, aiming to ensure the longevity and quality of life of pets, whilst also aiding in the control of disease outbreaks that could potentially affect human populations as well.
Prominent players in the companion animal vaccine market include Zoetis, Merck Animal Health (known as MSD Animal Health outside the United States and Canada), Boehringer Ingelheim, Elanco, Virbac, Vetoquinol, and Ceva Santé Animale. These companies are noteworthy for their extensive research and development efforts, comprehensive vaccine portfolios, and substantial contributions to veterinary medicine and overall animal health. Show Less Read more